Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0190
0.00 (0.00%)
Aug 6, 2026, 11:45 AM AEST
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 17.15 million as of August 7, 2026. Its market cap has increased by 14.57% in one year.
Market Cap
17.15M
Enterprise Value
14.13M
Revenue
3.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 17.15M, a decrease of -92.16%. That is a compound annual growth rate of -33.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 17.15M | -41.21% |
| Dec 31, 2025 | 29.17M | 140.15% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 45.25M |
| Nova Eye Medical | 42.73M |
| HeraMED | 39.35M |
| OncoSil Medical | 37.38M |
| CleanSpace Holdings | 32.35M |
| Control Bionics | 30.73M |
| ImpediMed | 21.97M |
| Micro-X | 21.69M |